SCHEMBL4294766

SCHEMBL4294766

CC(C)(C)OC(=O)NC1CCNCC1.O=Cc1nc(Cl)c2c(n1)NC(=O)CC2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 5/20 0.33
GAA P10253 1/20 0.32
JAK1 P23458 3/20 0.32
JAK2 O60674 2/20 0.32
JAK3 P52333 1/20 0.32
SMYD3 Q9H7B4 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
REN P00797 1/20 0.31
SSTR1 P30872 1/20 0.31
SSTR4 P31391 1/20 0.31
CKS1B P61024 1/20 0.31
SKP1 P63208 1/20 0.31
SKP2 Q13309 1/20 0.31
KDM1A O60341 1/20 0.31
MAOB P27338 1/20 0.31
PARP1 P09874 2/20 0.30
PIM1 P11309 1/20 0.30
PIM3 Q86V86 1/20 0.30
PIM2 Q9P1W9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4297417 0.90 BTK (0.33) BTKGAAJAK1JAK2SMYD3
SCHEMBL4302615 0.88 BTK (0.32) BTKGAAJAK1JAK2SMYD3
SCHEMBL4302688 0.81 SMYD3 (0.40) BTKGAAJAK1JAK2JAK3
SCHEMBL2820233 0.74 CRBN (0.32)
Formic Acid SCHEMBL7216484 0.71 BTK (0.48) BTKGAAKMT2AL3MBTL1KDM1A
SCHEMBL56856 0.71 EPHX1 (0.53) BTKGAAKMT2AL3MBTL1KDM1A
SCHEMBL4296620 0.70 GAA (0.37) GAASMYD3KMT2AL3MBTL1CKS1B
SCHEMBL4304869 0.70 PIM1 (0.35) BTKJAK1JAK2SMYD3KMT2A
Ammonia Solution, Strong SCHEMBL15021680 0.69 EPHX1 (0.52) BTKGAAKMT2AL3MBTL1KDM1A
Hydrochloric Acid SCHEMBL4158527 0.69 EPHX1 (0.52) BTKGAAKMT2AL3MBTL1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071592-B2 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones GLAXO GROUP LIMITED (GB) 2011-12-06 US disclosed
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES GLAXO GROUP LIMITED (GB) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES ETFA, NQO2, GNAQ BTK 2070/4885GAA 1815/4885JAK1 4866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.